Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology
NCT ID: NCT01971762
Last Updated: 2014-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
600 participants
OBSERVATIONAL
2011-04-30
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients diagnosed bacteremia by S. aureus
Follow recommendations based on scientific evidence to S. aureus bacteremia management
Not to follow recommendations based on scientific evidence to S. aureus bacteremia management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Follow recommendations based on scientific evidence to S. aureus bacteremia management
Not to follow recommendations based on scientific evidence to S. aureus bacteremia management
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical significant bacteremia by S. aureus
* Patient hospitalized
Exclusion Criteria
* Ambulatory patient
* End-of-life patients
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundación Pública Andaluza Progreso y Salud
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jesús Rodríguez-Baño
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario Virgen Macarena
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de Puerto Real
Puerto Real, Cádiz, Spain
Hospital Costa del Sol
Marbella, Málaga, Spain
Hospital de Torrecárdenas
Almería, , Spain
Hospital de barcelona - SCIAS
Barcelona, , Spain
Hospital de Cruces
Bilbao, , Spain
Hospital Puerta del Mar
Cadiz, , Spain
Hospital Reina Sofía
Córdoba, , Spain
Hospital Virgen de las Nieves
Granada, , Spain
Hospital Juan Ramón Jiménez
Huelva, , Spain
Hospital de San Pedro
Logroño, , Spain
Hospital Carlos Haya
Málaga, , Spain
Hospital Virgen de la Victoria
Málaga, , Spain
Hospital de la Arrixaca
Murcia, , Spain
Hospital de Valdecillas
Santander, , Spain
Hospital Universitario Virgen de la Macarena
Seville, , Spain
Hospital Virgen de Valme
Seville, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lopez-Cortes LE, Del Toro MD, Galvez-Acebal J, Bereciartua-Bastarrica E, Farinas MC, Sanz-Franco M, Natera C, Corzo JE, Lomas JM, Pasquau J, Del Arco A, Martinez MP, Romero A, Muniain MA, de Cueto M, Pascual A, Rodriguez-Bano J; REIPI/SAB group. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis. 2013 Nov;57(9):1225-33. doi: 10.1093/cid/cit499. Epub 2013 Aug 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FPS-STA-2011-01
Identifier Type: -
Identifier Source: org_study_id